2-Chloro-N-(2-ethyl-6-methylphenyl)acetamide

We are 2-Chloro-N-(2-ethyl-6-methylphenyl)acetamide CAS:32428-71-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 32428-71-0
Product Name: 2-Chloro-N-(2-ethyl-6-methylphenyl)acetamide
Other Name:
2-Chloro-N-(2-ethyl-6-methylphenyl)acetamide
2-Ethyl-6-Methyl-2-Chloroacetanilide
2-chloro-2'-ethyl-6'-methylacetanilide
N-chloroacetyl-2-ethyl-6-methylaniline
2-chloro-6'-methyl-2'-ethyl-acetanilide
chloroacetyl-2-ethyl-6-methylaniline
 
Density: 1.156g/cm3
Boiling Point: 343.1ºC at 760 mmHg
Molecular Formula: C11H14ClNO
Molecular Weight: 211.68800
Flash Point: 161.3ºC
Exact Mass: 211.07600
PSA: 29.10000
LogP: 2.80770
Index of Refraction: 1.566
 
Specification
Appearance: White crystals
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Propisochlor CAS: 86763-47-5.
Intermediates of Metolachlor CAS: 51218-45-2.
Intermediates of Acetochlor CAS: 34256-82-1.
Be used as pesticide intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2-Chloro-N-(2-ethyl-6-methylphenyl)acetamide


Related News: The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.ethyl oleate CAS:111-62-6 This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.7274-88-6 This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.3279-76-3 Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.

Related Products
Product Name
6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]-pyridine-3-acetic acid View Details
2′-Fluoroacetophenone View Details
2-Bromo-1-(4-methoxyphenyl)ethanone View Details
N-(4-(9-phenyl-9H-fluoren-9-yl)phenyl)-[1,1′-biphenyl]-4-amine manufacturer 10-Methoxy-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-one manufacturer 9-Bromo-1-nonanol manufacturer 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine manufacturer Triethyl O-Acetylcitrate Cas:77-89-4 manufacturer